-
Electronic (PDF)
-
Site License
-
Enterprisewide
Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review
GlobalData, April 2013, Pages: 43
Summary
Interleukin Genetics, Inc. (Interleukin) develops and distributes genetic tests for the personalized health market. The company offers its products and services under the brands Inherent Health and PCT. Inherent Health brand of genetic tests includes genetic tests in weight management, heart health, bone health and nutritional needs. PST Genetic Susceptibility Test is the genetic test that helps in identifying interleukin 1 gene that has variations leading to the periodontal disease. Its genetic test product pipeline includes Osteoarthritis Genetic Test for osteoarthritis. The company distributes its products through partnership with healthcare professionals, health and wellness companies, and distribution channels. Interleukin is headquartered in Waltham, Massachusetts, the US.
Interleukin Genetics, Inc. Key Recent Developments
Mar 28, 2013 Interleukin Genetics Reports Revenue Of $2.2m In 2012
Jan 03, 2013 Interleukin Genetics Appoints Scott Snyder As CMO
Nov 14, 2012 Interleukin Genetics Reports Q3 2012 Results
Aug 23, 2012 Interleukin Genetics Announces Executive Management Changes
This comprehensive SWOT profile of Interleukin Genetics, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
Interleukin Genetics, Inc. - Key Facts
Interleukin Genetics, Inc. - Key Employees
Interleukin Genetics, Inc. - Key Employee Biographies
Interleukin Genetics, Inc. - Major Products and Services
Interleukin Genetics, Inc. - Medical Equipment Pipeline Products Data
Interleukin Genetics, Inc. Pipeline Products by Equipment Type
Interleukin Genetics, Inc. Pipeline Products by Development Stage
Interleukin Genetics, Inc. - History
Interleukin Genetics, Inc. - Company Statement
Interleukin Genetics, Inc. - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Interleukin Genetics, Inc. - Business Description
Interleukin Genetics, Inc. - SWOT Analysis
SWOT Analysis - Overview
Interleukin Genetics, Inc. - Strengths
Strength - Focused Research and Development Activities
Strength - Strategic Collaborations
Strength - Improved Liquidity
Interleukin Genetics, Inc. - Weaknesses
Weakness - History of Operating Losses
Weakness - Dependence on Significant Customers
Interleukin Genetics, Inc. - Opportunities
Opportunity - Rising Healthcare Expenditure in the US
Opportunity - Market Growth in Emerging Economies
Opportunity - New Product Launches and Strong Pipeline
Interleukin Genetics, Inc. - Threats
Threat - Competitive Landscape
Threat - Stringent Government Regulations
Threat - Risk of Product Obsolescence
Interleukin Genetics, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Interleukin Genetics, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Interleukin Genetics, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Interleukin Genetics, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Interleukin Genetics, Inc., Recent Developments
Mar 28, 2013: Interleukin Genetics Reports Revenue Of $2.2m In 2012
Mar 04, 2013: Interleukin Genetics And RHSC Enter Into Preferred Participation Agreement For PST Genetic Test
Jan 03, 2013: Interleukin Genetics Appoints Scott Snyder As CMO
Nov 14, 2012: Interleukin Genetics Reports Q3 2012 Results
Aug 23, 2012: Interleukin Genetics Announces Executive Management Changes
Aug 14, 2012: Interleukin Genetics Reports Q2 2012 Results
Aug 06, 2012: University of Michigan Informs Interleukin Genetics Of Study Results Using PST Genetic Test In Determining Frequency Of Dental Cleanings
Jul 02, 2012: Interleukin Genetics Completes Private Placement Of Series B Convertible Preferred Stock For $3 Million
May 10, 2012: Interleukin Genetics Reports Q1 2012 Results
Mar 29, 2012: Interleukin Genetics Reports Revenue Of $2.9m In 2011
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer
List of Tables
Interleukin Genetics, Inc., Key Facts
Interleukin Genetics, Inc., Key Employees
Interleukin Genetics, Inc., Key Employee Biographies
Interleukin Genetics, Inc., Major Products and Services
Interleukin Genetics, Inc. Number of Pipeline Products by Equipment Type
Interleukin Genetics, Inc. Pipeline Products by Equipment Type
Interleukin Genetics, Inc. Number of Pipeline Products by Development Stage
Interleukin Genetics, Inc. Pipeline Products by Development Stage
Interleukin Genetics, Inc., History
Interleukin Genetics, Inc., Key Competitors
Interleukin Genetics, Inc., Ratios based on current share price
Interleukin Genetics, Inc., Annual Ratios
Interleukin Genetics, Inc., Interim Ratios
Interleukin Genetics, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Interleukin Genetics, Inc., Medical Equipment, Deals By Type, 2007 to YTD 2013
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Interleukin Genetics, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Interleukin Genetics, Inc. Pipeline Products by Equipment Type
Interleukin Genetics, Inc. Pipeline Products by Development Stage
Interleukin Genetics, Inc., Performance Chart (2007 - 2011)
Interleukin Genetics, Inc., Ratio Charts
Interleukin Genetics, Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013
Interleukin Genetics, Inc., Medical Equipment, Deals by Type, 2007 to YTD 2013
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Third Wave Technologies, Inc.
Allegro Diagnostics, Inc.
Clarient, Inc.
Satoris, Inc.
NBTY, Inc.
Myriad Genetics, Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
